Anabolicum vister is an oral steroid produced only in Italy. It is administered in an unusual form since it is either taken as a capsule or in drops. The latter type of administration is not used by athletes. In schools of medicine Anabolicum vister is used primarily in treating of the elderly, in particular women after menopause, and for the treatment of general diseases and symptoms of old age. This is due to the fact that Anabolicum vister is a very weak androgenic steroid. Anabolicum vister is a very weak steroid, which does not help athletes achieve significant improvements. As with all steroids common side effects in men include pain in the nipples and breast swelling (gynocomastia), etc. Get Your
Workout eBook! Enter Your
Quinbolone itself has very few androgenic effects, and most of what it does have are a result of its conversion to boldenone and its metabolites . Because of high doses necessary for androgenic effects, cost and inconvenience meant that quinbolone never proved to be commercially successful, and its clinical applications were fulfilled by alternative, more effective, steroids. Its illicit usage in bodybuilding and athletics likewise proved limited, though drug tests are still used to detect its metabolites as it remains a banned substance for most competitive sports.
Quinbolone was never produced in the US and has only been marketed in Italy under the trade name Anabolicum Vistar by Parke Davis. Quinbolone’s structure is very similar to methandrostenolone and boldenone. It is taken orally, but is not C-17 alpha alkylated; instead it contains a cyclopentenyl ether, making it more similar to equipoise than to dianabol. This eliminates the worry of liver toxicity; however, quinbolone is not very active orally because of the lack of C-17 alkylation. Quinbolone has a very short half-life and a probability of aromatization to estrogen and moderate affinity for the androgen receptor. This steroid can also be converted to potent 5-alpha reduced metabolites. There is some disagreement over whether the ether is removed through metabolism or not. If the ether is not removed, then the binding affinity for this steroid is likely to be reduced. Most of what can be said for boldenone applies to quinbolone except that quinbolone’s half-life is very short and the gut destroys much of it before getting into circulation. The anabolic to androgenic ratio shows this steroid to be fairly weak compared to methyltestosterone orally.